Explore our full content library.
Lonza vs WuXi Biologics: BIOSECURE Act & U.S. Manufacturing Strategy
Feb 12, 2026
Partner Interview
Lonza Group•CH•Large CapCharles River Laboratories InternationalWuXi BiologicsCatalentThermo Fisher ScientificDanaherSwitching CostsMission Critical Products & ServicesOEMs w/ Installed BaseSerial AcquirerHealth CareFeb 12, 2026
Medpace Holdings: Key Considerations in Selecting a CRO
Nov 26, 2025
Partner Interview
Medpace•US•Large CapIQVIAICONThermo Fisher ScientificSyneos HealthParexel InternationalFortreaCharles River Laboratories InternationalLonza GroupSwitching CostsMission Critical Products & ServicesOEMs w/ Installed BaseHealth CareNov 26, 2025
AGC Biologics & Western vs Chinese CDMOs
Sep 19, 2025
Partner Interview
AGC BiologicsWuXi BiologicsBayerLonza GroupThermo Fisher ScientificSartorius Stedim BiotechMerckPfizerCatalentSwitching CostsMission Critical Products & ServicesOEMs w/ Installed BaseHealth CareSep 19, 2025
Sartorius: Upstream Bioprocessing Market Dominance
Aug 18, 2025
Partner Interview
Sartorius Stedim Biotech•FR•Large CapDanaherGE AerospacePall CorporationMerckThermo Fisher Scientific3MRepligenLonza GroupRocheSwitching CostsProcess PowerOEMs w/ Installed BaseMission Critical Products & ServicesSerial AcquirerHealth CareIndustrialsMaterialsAug 18, 2025
Aldevron: mRNA, Plasmids and Synthetic DNA
Jul 30, 2025
Jul 30, 2025
Sartorius: Building Customer Lock-In Across the Biotech Lifecycle
Jun 26, 2025
Partner Interview
Sartorius Stedim BiotechDanaherThermo Fisher ScientificLonza GroupNovartisSanofiBioNTechSwitching CostsOEMs w/ Installed BaseMission Critical Products & ServicesSerial AcquirerHealth CareJun 26, 2025
Lonza, WuXi Biologics & CDMO Global Market: Competitive Landscape Evolution
Feb 13, 2025
Partner Interview
Lonza Group•CH•Large CapPfizerEli Lilly andNovo NordiskRocheWuXi BiologicsAGC BiologicsHealth CareFeb 13, 2025
Lonza: CDMO Market Capacity
Jan 20, 2025
Partner Interview
Lonza Group•CH•Large CapCatalentSartorius Stedim BiotechAbbVieAvid BioservicesDanaherThermo Fisher ScientificCharles River Laboratories InternationalSwitching CostsOEMs w/ Installed BaseMission Critical Products & ServicesSerial AcquirerHealth CareJan 20, 2025
Danaher vs Thermo Fisher: Plasmid Manufacturing & Gene Therapy Positioning
Jan 14, 2025
Jan 14, 2025
Danaher: Aldevron & DNA Plasmid Manufacturing
Dec 16, 2024
Dec 16, 2024
Lifecore Biomedical: Customer Mix, Switching Cost & Power in the CDMO Value Chain
Oct 6, 2024
Partner Interview
Landec•US•Small CapNovo NordiskLonza GroupCatalentHealth CareOct 6, 2024
IP Research Analysis
Danaher Cytiva: History, Moat, and Bundling Pall Filters
Oct 2, 2024
In Practise Research
IP ResearchDanaher•US•Large CapThermo Fisher ScientificMerckRepligenLonza GroupSartoriusSartorius Stedim BiotechBio-Rad LaboratoriesSwitching CostsMission Critical Products & ServicesOEMs w/ Installed BaseSerial AcquirerHealth Care
Oct 2, 2024
MaxCyte: Electroporation Technology, Cell & Gene Therapy & Competition
Sep 25, 2023
Partner Interview
MaxCyte•US•Small CapLonza GroupBio-Rad LaboratoriesHealth CareSep 25, 2023
You've reached the end